| Autor: |
Prados-Ojeda JL; Mental Health Department, Reina Sofia University Hospital, 14004 Cordoba, Spain.; Morphological and Socio-Sanitary Sciences, University of Cordoba, 14004 Cordoba, Spain.; Maimonides Institute of Biomedical Research of Córdoba (IMIBIC), 14004 Cordoba, Spain., Luque-Luque R; Mental Health Department, Reina Sofia University Hospital, 14004 Cordoba, Spain.; Morphological and Socio-Sanitary Sciences, University of Cordoba, 14004 Cordoba, Spain.; Maimonides Institute of Biomedical Research of Córdoba (IMIBIC), 14004 Cordoba, Spain., Gordillo-Urbano RM; Mental Health Department, Reina Sofia University Hospital, 14004 Cordoba, Spain., Guler I; Maimonides Institute of Biomedical Research of Córdoba (IMIBIC), 14004 Cordoba, Spain., López-Medina C; Maimonides Institute of Biomedical Research of Córdoba (IMIBIC), 14004 Cordoba, Spain.; Medical and Surgical Sciences Department, University of Cordoba, 14004 Cordoba, Spain.; Rheumatology Department, Reina Sofia University Hospital, 14004 Cordoba, Spain., Collantes-Estévez E; Maimonides Institute of Biomedical Research of Córdoba (IMIBIC), 14004 Cordoba, Spain.; Medical and Surgical Sciences Department, University of Cordoba, 14004 Cordoba, Spain.; Rheumatology Department, Reina Sofia University Hospital, 14004 Cordoba, Spain., Escudero-Contreras A; Maimonides Institute of Biomedical Research of Córdoba (IMIBIC), 14004 Cordoba, Spain.; Medical and Surgical Sciences Department, University of Cordoba, 14004 Cordoba, Spain.; Rheumatology Department, Reina Sofia University Hospital, 14004 Cordoba, Spain. |
| Abstrakt: |
Inflammatory and autoimmune processes have been associated with the onset of depressive and psychotic symptoms. Rheumatoid arthritis (RA) and spondyloarthritis (SpA) are rheumatic diseases with an inflammatory etiology. A high prevalence of depressive and anxiety-related comorbidity has been reported for both diseases, with no evidence of a greater prevalence of psychosis. The objective of the present study was to evaluate for the first time subclinical psychotic symptoms in patients with RA and SpA. This is a cross-sectional, single-center study including RA and SpA patients, as well as healthy controls. Abnormal psychotic experiences (positive, negative, and depressive symptoms) were evaluated using the Community Assessment of Psychic Experiences (CAPE-42). Functional capacity was evaluated using the Short-Form Health Survey SF-12. We compared the CAPE and SF-12 scores between the three groups. We recruited 385 individuals: 218 with RA, 100 with SpA, and 67 healthy controls. According to the CAPE scale, the frequency of subclinical psychotic symptoms was greater in patients than in healthy controls (RA, 1.90 vs. 1.63, p < 0.001; SpA, 1.88 vs. 1.63, p = 0.001). Distress was also greater in patients than in controls owing to the presence of symptoms. No differences were observed between the three groups for the mental dimension scores in the SF-12 Health Survey (43.75 in RA, 45.54 in SpA, and 43.19 in healthy controls). Our findings point to a greater prevalence of subclinical psychotic symptoms in patients with RA and patients with SpA than in the general population. The results suggest an association between inflammation and depression/subclinical psychotic symptoms. |
